--- title: "Tenax Therapeutics (TENX) news: offering" url: "https://aibio.space/companies/tenax-therapeutics/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "TENX offering news: Tenax Therapeutics agrees to $25 million private placement with RTW Investments. Tenax Therapeutics, Inc. (NASDAQ: TENX), United States." --- TENX Tenax Therapeutics, Inc. NASDAQ · United States # Tenax Therapeutics (TENX) news TENX offering news Financings · 2025-03-06 ## [Tenax Therapeutics agrees to $25 million private placement with RTW Investments](https://aibio.space/news/tenax-therapeutics-agrees-25-million-private-placement-rtw-investments/) RTW is to buy 378,346 shares at $6.04 and pre-funded warrants for 3,760,726 shares. Tenax plans to use the money for Phase 3 trials. ## Latest Tenax Therapeutics news We have not published a story on Tenax Therapeutics yet. When there is news, it will appear here. ## Tenax Therapeutics at a glance - **Ticker**: TENX - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $118.0 million ### Related companies - [Inhibikase Therapeutics](https://aibio.space/companies/inhibikase-therapeutics/) NASDAQ: IKT - [Minerva Neurosciences](https://aibio.space/companies/minerva-neurosciences/) NASDAQ: NERV - [Alpha Teknova](https://aibio.space/companies/alpha-teknova/) NASDAQ: TKNO - [Arcturus Therapeutics Holdings](https://aibio.space/companies/arcturus-therapeutics/) NASDAQ: ARCT - [Xilio Therapeutics](https://aibio.space/companies/xilio-therapeutics/) NASDAQ: XLO - [Vericel](https://aibio.space/companies/vericel/) NASDAQ: VCEL - [Ardelyx](https://aibio.space/companies/ardelyx/) NASDAQ: ARDX - [Acura Pharmaceuticals](https://aibio.space/companies/acura-pharmaceuticals/) OTC: ACUR ### Also on NASDAQ - [Ocugen](https://aibio.space/companies/ocugen/) OCGN - [Genenta Science S.p.A.](https://aibio.space/companies/genenta-science-s-p-a/) GNTA - [Mirum Pharmaceuticals](https://aibio.space/companies/mirum-pharmaceuticals/) MIRM - [CytoMed Therapeutics](https://aibio.space/companies/cytomed-therapeutics/) GDTC - [ProKidney](https://aibio.space/companies/prokidney/) PROK - [PHIBRO ANIMAL HEALTH CORP](https://aibio.space/companies/phibro-animal-health/) PAHC ## Tenax Therapeutics annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [$32.7 million](https://www.sec.gov/Archives/edgar/data/34956/000119312526099393/) | [$12.7 million](https://www.sec.gov/Archives/edgar/data/34956/000119312526099393/) | | Net income (loss) | [-$52.6 million](https://www.sec.gov/Archives/edgar/data/34956/000119312526099393/) | [-$17.6 million](https://www.sec.gov/Archives/edgar/data/34956/000119312526099393/) | | Cash from operations | [-$35.8 million](https://www.sec.gov/Archives/edgar/data/34956/000119312526099393/) | [-$14.8 million](https://www.sec.gov/Archives/edgar/data/34956/000119312526099393/) | | Cash and equivalents | [$97.6 million](https://www.sec.gov/Archives/edgar/data/34956/000119312526099393/) | [$94.9 million](https://www.sec.gov/Archives/edgar/data/34956/000119312526099393/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $118.0 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Tenax Therapeutics Has Tenax Therapeutics raised money recently? Our latest story on this, dated Mar 6, 2025: "Tenax Therapeutics agrees to $25 million private placement with RTW Investments". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/tenax-therapeutics-agrees-25-million-private-placement-rtw-investments/). What is the ticker symbol of Tenax Therapeutics? Tenax Therapeutics, Inc. trades under the ticker TENX on NASDAQ. Where is Tenax Therapeutics listed? Tenax Therapeutics, Inc. is listed on NASDAQ. What is the SEC CIK of Tenax Therapeutics? The SEC Central Index Key (CIK) for Tenax Therapeutics, Inc. is 34956. Its filings are on SEC EDGAR. How many shares does Tenax Therapeutics have outstanding? 37,423,917 shares as of 2026-07-28, per the cover page of its 10-Q filed 2026-07-31. Which country or territory is Tenax Therapeutics listed under? Our directory records Tenax Therapeutics, Inc. under United States. What does Tenax Therapeutics do? Our directory classifies Tenax Therapeutics, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Tenax Therapeutics? The ISIN recorded for Tenax Therapeutics, Inc. is US88032L6056. Does aibio.space cover Tenax Therapeutics? aibio.space lists Tenax Therapeutics, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Tenax Therapeutics incorporated? SEC records list its state or country of incorporation as DE. Is Tenax Therapeutics profitable? Tenax Therapeutics, Inc. reported a net loss of $52.6 million for the fiscal year ended Dec 31, 2025, and used $35.8 million of cash in operations, per its annual report to the SEC. How much does Tenax Therapeutics spend on research and development? $32.7 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Tenax Therapeutics have? $118.0 million in cash at Jun 30, 2026, per its 10-Q. What is the latest Tenax Therapeutics (TENX) stock news? Our latest story on Tenax Therapeutics, dated Mar 6, 2025: "Tenax Therapeutics agrees to $25 million private placement with RTW Investments". RTW is to buy 378,346 shares at $6.04 and pre-funded warrants for 3,760,726 shares. Tenax plans to use the money for Phase 3 trials. [Source](https://aibio.space/news/tenax-therapeutics-agrees-25-million-private-placement-rtw-investments/). What is Tenax Therapeutics's market cap? We do not publish live share prices. In its annual report, Tenax Therapeutics, Inc. put the market value of shares held by non-affiliates (public float) at $23.8 million as of Jun 30, 2025. ## Investor discussion: Tenax Therapeutics Members talk about Tenax Therapeutics (TENX). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Tenax Therapeutics, newest first. Each line links the filing it comes from. 1. 2026-04-22 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 5.02,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/34956/000119312526168521/d81080dex991.htm) 2. 2026-03-24 Financings Set up an at-the-market program to sell shares over time. SEC Form S-3. [Source](https://www.sec.gov/Archives/edgar/data/34956/000165495426002661/tennx_s3.htm) 3. 2026-03-10 Legal Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 10-K. [Source](https://www.sec.gov/Archives/edgar/data/34956/000119312526099393/tennx-20251231.htm) 4. 2025-03-25 Legal Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 10-K. [Source](https://www.sec.gov/Archives/edgar/data/34956/000095017025044398/tennx-20241231.htm) 5. 2025-03-06 Financings Reported a financing. SEC Form 8-K (Items 1.01,3.02,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/34956/000165495425002385/tenx_ex991.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:TENX on TradingView](https://www.tradingview.com/symbols/NASDAQ-TENX/). ## SEC filings and registration - **SEC name**: Tenax Therapeutics, Inc. - **CIK**: 34956 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: TENX (Nasdaq) - **State or country of incorporation**: DE - **Fiscal year ends**: December 31 - **Filer category**: Non-accelerated filer
Smaller reporting company - **Business address**: 101 GLEN LENNOX DRIVE, CHAPEL HILL, NC, 27517 - **Phone**: 919-855-2100 - **Shares outstanding**: 37,423,917 as of 2026-07-28 (10-Q filed 2026-07-31) - **Former names**: OXYGEN BIOTHERAPEUTICS, INC.; SYNTHETIC BLOOD INTERNATIONAL INC ### Recent filings (8-K and 6-K are the company's own announcements) - [8-K](https://www.sec.gov/Archives/edgar/data/34956/000119312526417939/d139658d8k.htm) filed 2026-10-08 - [8-K](https://www.sec.gov/Archives/edgar/data/34956/000119312526385910/d43255d8k.htm) filed 2026-09-09 - [8-K](https://www.sec.gov/Archives/edgar/data/34956/000119312526341236/d115761d8k.htm) filed 2026-08-10 - [10-Q](https://www.sec.gov/Archives/edgar/data/34956/000119312526327455/tennx-20260630.htm) filed 2026-07-31 - [8-K](https://www.sec.gov/Archives/edgar/data/34956/000119312526326784/d90330d8k.htm) filed 2026-07-31 - [8-K](https://www.sec.gov/Archives/edgar/data/34956/000119312526293485/d20457d8k.htm) filed 2026-07-02 - [8-K](https://www.sec.gov/Archives/edgar/data/34956/000119312526290661/d117070d8k.htm) filed 2026-06-30 - [8-K](https://www.sec.gov/Archives/edgar/data/34956/000119312526288600/d251626d8k.htm) filed 2026-06-29 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000034956), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Tenax Therapeutics, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TENX, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Tenax Therapeutics, Inc. - **Ticker**: TENX - **Listing**: NASDAQ - **Country or territory**: United States - **Business scope**: Pharmaceuticals: Major - **ISIN**: US88032L6056 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-TENX/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/tenax-therapeutics/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Tenax Therapeutics (TENX) news: offering", 2026-10-31, https://aibio.space/companies/tenax-therapeutics/